References
- American College of Obstetricians and Gynecologists. Technical Bulletin 1983: 70(Jun): 1–5
- Judd HL, Cleary RE, Creasman WT, et al. Estrogen replacement therapy. Obstet Gynecol 1981: 58(3): 267–75
- Nordin BE, Aaron J, Speed R, et al. Bone formation and resorption as the determinants of trabecular bone volume in postmenopausal osteoporosis. Lancet 1981: 2(8241): 227–9
- Stevenson JC, Abeyasekera G, Hillyard CJ, et al. Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens. Lancet 1981: 1(8222): 693–5
- Albright F, Smith PH, Richardson AM. Postmenopausal osteoporosis: its clinical features. JAMA 1941: 116(22): 2465–74
- Henneman PH, Wallach S. A review of the prolonged use of estrogens and androgens in postmenopausal and senile osteoporosis. Arch Intern Med 1957: 100(6)715–23
- Nachtigall LE, Nachtigall RH, Nachtigall RD, et al. Estrogen replacement therapy. I. A 10-year prospective study in the relationship to osteoporosis. Obstet Gynecol 1979: 53(3): 277–81
- Lindsay R, Hart DM, Aitken JM, et al. Long-term prevention of postmenopausal osteoporosis by oestrogen. Lancet 1976: 1(7968): 1038–41
- Lindsay R, Hart DM, MacLean A, et al. Bone response to termination of oestrogen treatment. Lancet 1978: 1(8078): 1325–7
- Recker RR, Saville PD, Heaney RP. Effect of estrogens and calcium carbonate on bone loss in postmenopausal women. Ann Intern Med 1977: 87(6)649–55
- Christiansen C, Christensen MS, McNair P, et al. Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females. Eur J Clin Invest 1980: 10(4): 273–9
- Weiss NS, Ure CL, Ballard JH, et al. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med 1980: 303(21): 1195–8
- Meema S, Bunker ML, Meema HE. Preventive effect of estrogen on postmenopausal bone loss. Arch Intern Med 1975: 135(11): 1436–40
- Ziel HK, Finkle WD. Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med 1975: 293(23): 1167–70
- Smith DC, Prentice R, Thompson DJ, et al. Association of exogenous estrogen and endometrial carcinoma. N Engl J Med 1975: 293(23): 1164–7
- Mack TM, Pike MC, Henderson BE, et al. Estrogens and endometrial cancer in a retirement community. N Engl J Med 1976: 294(23): 1262–7
- Antunes CM, Stolley PD, Rosenshein NB, et al. Endometrial cancer and estrogen use: report of a large case-control study. N Engl J Med 1979: 300(1): 9–13
- Gusberg SB. The individual at high risk for endometrial carcinoma. Am J Obstet Gynecol 1976: 126(5): 535–42
- Schiff I. Sela HK, Cramer D, et al. Endometrial hyperplasia in women on cyclic or continuous estrogen regimens. Fertil Steril 1982: 37(1): 79–82
- Whitehead MI. The effects of estrogens and progestogens on the postmenopausal endometrium. Maturitas 1978: 1(2): 87–98
- Hoover R, Gray LA Sr, Cole P. et al. Menopausal estrogens and breast cancer. N Engl J Med 1976: 295 (8): 401–5
- Gambrell RD Jr. Massey FM. Castaneda TA, et al. Estrogen therapy in breast cancer in postmenopausal women. J Am Geriatr Soc 1980: 28(6): 251–7
- Gambrell RD Jr, Maier RC, Sanders BI. Decreased incidence of breast cancer in postmenopausal estrogen-progestogen users. Obstet Gynecol 1983: 62 (4): 435–43